Nifty
Sensex
:
:
14677.80
48732.55
-18.70 (-0.13%)
41.75 (0.09%)

Chemicals

Rating :
72/99

BSE: 532834 | NSE: CAMLINFINE

165.25
14-May-2021
  • Open
  • High
  • Low
  • Previous Close
  •  166.55
  •  173.50
  •  162.50
  •  165.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  525196
  •  876.67
  •  177.80
  •  35.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,105.06
  • 53.47
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,565.83
  • N/A
  • 3.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 21.62%
  • 7.56%
  • 31.31%
  • FII
  • DII
  • Others
  • 4.71%
  • 18.65%
  • 16.15%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.84
  • 16.48
  • 13.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.15
  • 8.05
  • 55.97

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.15
  • -3.28
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.92
  • 22.48
  • 21.68

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.54
  • 3.01
  • 2.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.08
  • 36.98
  • 17.50

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
297.93
273.88
8.78%
256.81
222.28
15.53%
305.74
260.12
17.54%
292.87
268.03
9.27%
Expenses
251.15
244.33
2.79%
223.17
192.26
16.08%
254.67
224.57
13.40%
258.58
251.23
2.93%
EBITDA
46.77
29.55
58.27%
33.64
30.01
12.10%
51.08
35.56
43.64%
34.29
16.80
104.11%
EBIDTM
15.70%
10.79%
13.10%
13.50%
16.71%
13.67%
11.71%
6.27%
Other Income
4.42
1.38
220.29%
1.28
0.64
100.00%
0.67
3.02
-77.81%
2.77
4.60
-39.78%
Interest
10.02
8.28
21.01%
8.13
14.42
-43.62%
10.76
8.30
29.64%
15.23
7.37
106.65%
Depreciation
13.36
8.41
58.86%
9.63
7.68
25.39%
9.48
7.59
24.90%
9.13
7.31
24.90%
PBT
27.81
14.25
95.16%
17.17
8.56
100.58%
31.51
22.68
38.93%
12.71
6.72
89.14%
Tax
8.39
10.43
-19.56%
7.51
1.04
622.12%
10.95
6.25
75.20%
10.65
0.36
2,858.33%
PAT
19.42
3.83
407.05%
9.66
7.52
28.46%
20.56
16.43
25.14%
2.05
6.36
-67.77%
PATM
6.52%
1.40%
3.76%
3.38%
6.72%
6.32%
0.70%
2.37%
EPS
1.21
0.43
181.40%
0.49
0.57
-14.04%
1.27
1.28
-0.78%
0.22
0.60
-63.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,153.35
1,049.15
892.17
720.60
533.93
489.34
558.27
508.67
373.62
335.25
171.67
Net Sales Growth
12.60%
17.60%
23.81%
34.96%
9.11%
-12.35%
9.75%
36.15%
11.45%
95.29%
 
Cost Of Goods Sold
571.96
533.78
474.80
422.44
260.51
203.10
270.49
275.73
164.64
167.52
113.41
Gross Profit
581.39
515.37
417.36
298.16
273.42
286.24
287.78
232.94
208.98
167.73
58.26
GP Margin
50.41%
49.12%
46.78%
41.38%
51.21%
58.50%
51.55%
45.79%
55.93%
50.03%
33.94%
Total Expenditure
987.57
913.94
819.26
705.95
503.23
397.55
474.10
449.20
327.56
306.22
156.13
Power & Fuel Cost
-
76.38
80.42
61.43
46.35
47.43
58.00
51.43
57.06
55.65
8.71
% Of Sales
-
7.28%
9.01%
8.52%
8.68%
9.69%
10.39%
10.11%
15.27%
16.60%
5.07%
Employee Cost
-
99.71
87.89
72.87
61.09
40.05
40.58
34.37
30.10
23.69
10.41
% Of Sales
-
9.50%
9.85%
10.11%
11.44%
8.18%
7.27%
6.76%
8.06%
7.07%
6.06%
Manufacturing Exp.
-
50.73
41.56
34.70
31.04
37.04
35.06
26.59
24.03
12.88
5.57
% Of Sales
-
4.84%
4.66%
4.82%
5.81%
7.57%
6.28%
5.23%
6.43%
3.84%
3.24%
General & Admin Exp.
-
50.25
44.15
36.86
38.28
24.72
21.21
17.36
17.74
11.76
6.97
% Of Sales
-
4.79%
4.95%
5.12%
7.17%
5.05%
3.80%
3.41%
4.75%
3.51%
4.06%
Selling & Distn. Exp.
-
50.02
46.92
39.48
33.48
25.33
20.17
17.78
15.00
6.73
6.37
% Of Sales
-
4.77%
5.26%
5.48%
6.27%
5.18%
3.61%
3.50%
4.01%
2.01%
3.71%
Miscellaneous Exp.
-
53.06
43.52
38.17
32.48
19.88
28.58
25.93
18.99
27.99
6.37
% Of Sales
-
5.06%
4.88%
5.30%
6.08%
4.06%
5.12%
5.10%
5.08%
8.35%
2.73%
EBITDA
165.78
135.21
72.91
14.65
30.70
91.79
84.17
59.47
46.06
29.03
15.54
EBITDA Margin
14.37%
12.89%
8.17%
2.03%
5.75%
18.76%
15.08%
11.69%
12.33%
8.66%
9.05%
Other Income
9.14
3.43
13.79
12.91
15.65
4.27
8.38
11.84
11.16
11.84
1.80
Interest
44.14
47.63
40.95
31.80
30.58
24.44
23.82
24.66
20.11
16.69
9.17
Depreciation
41.60
32.80
28.99
26.65
21.80
17.06
16.25
11.79
13.61
13.51
5.65
PBT
89.20
58.20
16.75
-30.90
-6.03
54.57
52.48
34.86
23.51
10.67
2.52
Tax
37.50
28.37
13.69
-6.75
-1.58
14.20
-2.21
6.13
8.38
6.94
1.76
Tax Rate
42.04%
48.75%
81.73%
21.84%
26.20%
28.39%
-4.18%
17.58%
35.64%
64.14%
19.21%
PAT
51.69
30.32
0.63
-29.81
-11.20
35.82
55.04
28.74
15.12
3.88
7.40
PAT before Minority Interest
39.37
29.83
3.06
-24.14
-4.46
35.82
55.04
28.74
15.12
3.88
7.40
Minority Interest
-12.32
0.49
-2.43
-5.67
-6.74
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.48%
2.89%
0.07%
-4.14%
-2.10%
7.32%
9.86%
5.65%
4.05%
1.16%
4.31%
PAT Growth
51.41%
4,712.70%
-
-
-
-34.92%
91.51%
90.08%
289.69%
-47.57%
 
EPS
4.05
2.38
0.05
-2.34
-0.88
2.81
4.32
2.25
1.19
0.30
0.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
403.14
370.88
371.16
212.58
176.22
134.87
93.30
65.38
52.91
46.45
Share Capital
12.13
12.13
12.12
10.37
9.67
9.59
9.44
9.39
9.36
9.31
Total Reserves
390.57
336.37
336.62
200.53
166.55
125.19
83.66
55.90
43.45
37.06
Non-Current Liabilities
185.44
154.88
72.63
32.51
11.69
16.84
25.47
40.82
36.29
42.94
Secured Loans
176.24
189.02
104.63
47.51
21.45
28.06
28.52
30.72
26.02
39.95
Unsecured Loans
35.27
4.62
5.61
3.81
0.00
0.00
0.00
6.95
6.97
0.06
Long Term Provisions
2.85
2.37
1.96
2.14
1.85
1.47
0.98
0.00
0.00
0.00
Current Liabilities
547.83
460.39
470.91
385.72
279.94
261.53
245.88
263.28
196.40
94.91
Trade Payables
173.72
164.61
177.79
78.40
95.31
106.55
100.01
157.47
87.22
59.53
Other Current Liabilities
81.51
43.92
39.04
27.45
27.40
19.50
27.73
13.74
11.29
5.54
Short Term Borrowings
278.07
244.34
246.79
269.90
145.70
120.95
104.01
79.50
88.53
23.37
Short Term Provisions
14.53
7.52
7.29
9.97
11.53
14.53
14.13
12.57
9.36
6.46
Total Liabilities
1,193.38
1,045.55
976.92
648.42
467.85
413.24
364.65
369.48
285.60
184.30
Net Block
305.79
272.44
278.10
200.88
140.27
106.43
83.15
83.28
73.82
68.85
Gross Block
436.11
359.11
342.34
213.71
359.66
295.11
283.15
251.04
226.08
212.01
Accumulated Depreciation
130.32
86.67
64.24
12.82
219.38
188.69
199.99
167.76
152.27
143.16
Non Current Assets
518.42
373.07
311.37
229.03
168.13
114.54
107.90
86.28
78.66
74.55
Capital Work in Progress
178.78
59.00
13.62
7.62
25.06
2.82
22.08
0.76
2.23
3.30
Non Current Investment
7.36
7.28
7.33
7.16
1.09
1.09
1.21
1.23
1.24
1.22
Long Term Loans & Adv.
24.84
32.06
11.31
7.73
1.70
4.21
1.46
1.00
1.37
1.17
Other Non Current Assets
1.65
2.29
1.01
5.62
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
674.96
672.48
665.55
419.40
299.72
298.69
256.75
283.20
206.94
109.76
Current Investments
0.00
3.25
108.08
11.70
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
298.15
285.41
239.02
197.80
173.32
136.38
109.20
149.00
84.36
33.12
Sundry Debtors
252.80
209.32
205.35
144.89
75.48
113.42
101.32
87.06
90.17
50.33
Cash & Bank
64.79
103.44
48.08
31.24
18.90
19.26
15.80
25.74
10.23
13.13
Other Current Assets
59.22
19.84
14.10
13.00
32.03
29.63
30.42
21.40
22.19
13.18
Short Term Loans & Adv.
39.47
51.21
50.92
20.77
20.16
14.87
17.56
19.66
19.61
12.12
Net Current Assets
127.12
212.09
194.64
33.68
19.78
37.16
10.87
19.92
10.54
14.85
Total Assets
1,193.38
1,045.55
976.92
648.43
467.85
413.23
364.65
369.48
285.60
184.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
86.02
-9.00
-15.41
-8.69
71.57
46.26
26.74
55.61
-31.86
4.18
PBT
58.20
16.69
-30.90
-6.03
50.02
52.48
34.86
23.51
10.67
2.52
Adjustment
86.49
70.35
40.90
46.70
48.89
47.26
40.28
32.66
26.51
14.74
Changes in Working Capital
-40.76
-79.83
-15.27
-39.00
-15.14
-42.60
-38.73
5.83
-63.80
-11.18
Cash after chg. in Working capital
103.94
7.22
-5.27
1.67
83.77
57.14
36.41
62.00
-26.62
6.09
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-17.92
-16.22
-10.14
-10.36
-12.20
-10.88
-9.67
-6.39
-5.25
-1.91
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-90.12
-1.94
-148.59
-83.14
-65.67
-26.28
-32.16
-18.66
-9.21
-17.46
Net Fixed Assets
-153.66
-67.82
-7.46
57.11
-37.27
-23.68
-1.87
-12.66
-13.00
-10.18
Net Investments
-5.05
79.12
-104.14
-37.24
-2.13
-0.77
-2.48
0.00
0.15
1.92
Others
68.59
-13.24
-36.99
-103.01
-26.27
-1.83
-27.81
-6.00
3.64
-9.20
Cash from Financing Activity
3.25
25.67
181.82
90.92
-6.87
-15.48
-6.29
-21.44
38.17
23.03
Net Cash Inflow / Outflow
-0.85
14.74
17.82
-0.92
-0.97
4.49
-11.71
15.51
-2.90
9.75
Opening Cash & Equivalents
53.21
38.48
20.65
8.03
8.99
4.50
16.21
10.23
13.13
3.38
Closing Cash & Equivalent
52.37
53.21
38.48
20.65
8.03
8.99
4.50
25.74
10.23
13.13

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
33.21
28.74
28.77
20.34
18.23
14.06
9.86
6.95
5.64
4.98
ROA
2.66%
0.30%
-2.97%
-0.80%
8.13%
14.15%
7.83%
4.62%
1.65%
4.87%
ROE
7.94%
0.88%
-8.63%
-2.30%
23.04%
48.31%
36.29%
25.61%
7.82%
19.64%
ROCE
12.02%
7.32%
0.14%
5.45%
22.86%
28.50%
27.41%
23.65%
18.81%
19.26%
Fixed Asset Turnover
2.64
2.54
2.60
1.91
1.54
1.97
1.94
1.60
1.55
1.27
Receivable days
80.39
84.82
88.44
73.54
68.37
68.69
66.48
84.48
75.55
97.40
Inventory Days
101.51
107.28
110.30
123.85
112.09
78.55
91.12
111.24
63.17
62.28
Payable days
72.27
77.53
73.54
64.72
89.70
89.36
114.87
132.61
84.56
129.85
Cash Conversion Cycle
109.63
114.57
125.19
132.67
90.76
57.88
42.72
63.10
54.15
29.83
Total Debt/Equity
1.31
1.32
1.07
1.57
1.02
1.19
1.61
1.93
2.36
1.47
Interest Cover
2.22
1.41
0.03
0.80
3.05
3.22
2.41
2.17
1.65
2.00

News Update:


  • Camlin Fine Sciences gets nod to acquire additional 35% stake in subsidiary company
    9th Feb 2021, 11:20 AM

    Post completion of the said acquisition, Dresen will become a wholly-owned subsidiary of the Company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.